Moebius syndrome in fetus occurs due to maternal intake of:
**Core Concept**
Moebius syndrome is a rare neurological disorder characterized by facial paralysis and inability to move the eyes from side to side. It is a congenital condition, often resulting from disruptions in fetal development, particularly in the cranial nerves responsible for facial movements.
**Why the Correct Answer is Right**
The correct answer is linked to the teratogenic effects of a specific medication. Moebius syndrome has been associated with maternal exposure to a particular anticonvulsant during pregnancy. This medication disrupts the normal development of the facial nerve (cranial nerve VII) and the abducens nerve (cranial nerve VI), leading to the characteristic symptoms of the syndrome. The exact mechanism involves interference with the migration of neural crest cells, which are crucial for the formation of these cranial nerves.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because there is no established link between maternal intake of this substance and Moebius syndrome.
**Option B:** This option is incorrect because while it is a known teratogen, it is not specifically associated with Moebius syndrome.
**Option C:** This option is incorrect because it is not a known teratogen or associated with Moebius syndrome.
**Clinical Pearl / High-Yield Fact**
Moebius syndrome should be considered in the differential diagnosis of congenital facial paralysis, particularly in cases where there is a history of maternal anticonvulsant use during pregnancy. It is essential to ask about medication use during pregnancy when evaluating a child with unexplained facial weakness or paralysis.
**Correct Answer:** C. A specific anticonvulsant (valproic acid) is associated with an increased risk of Moebius syndrome in the fetus.